The failure of current immunotherapy for malignant glioma. Tumor-derived TGF-β, T-cell apoptosis, and the immune privilege of the brain
- 30 September 1995
- journal article
- review article
- Published by Elsevier in Brain Research Reviews
- Vol. 21 (2), 128-151
- https://doi.org/10.1016/0165-0173(95)00010-0
Abstract
No abstract availableKeywords
This publication has 100 references indexed in Scilit:
- Mechanism of activation of the TGF-β receptorNature, 1994
- Cytokine gene transfer in tumor inhibition and tumor therapy: where are we now?Immunology Today, 1994
- Cytokine gene expression on glioma cell lines and specimensJournal of Neuro-Oncology, 1994
- Growth inhibition of subcutaneously transplanted human glioma by transfection-induced tumor necrosis factor-? and augmentation of the effect by ?-interferonJournal of Neuro-Oncology, 1994
- Molecular cloning and expression of the fas ligand, a novel member of the tumor necrosis factor familyCell, 1993
- Therapy of recurrent high grade gliomas with surgery, and autologous mitogen activated IL-2 stimulated killer (MAK) Lymphocytes: I. Enhancement of MAK lytic activity and cytokine production by PHA and clinical use of PHAJournal of Neuro-Oncology, 1993
- Systemic chemotherapy combined with local adoptive immunotherapy cures rats bearing 9L gliosarcomaJournal of Neuro-Oncology, 1993
- Cytokine gene expression in primary brain tumours, metastases and meningiomas suggests specific transcription patternsEuropean Journal Of Cancer, 1993
- Brain Tumor Working Group Report on the 9th International Conference on Brain Tumor Research and TherapyJournal of Neuro-Oncology, 1993
- Targeted disruption of the mouse transforming growth factor-β1 gene results in multifocal inflammatory diseaseNature, 1992